Kilitch Drugs - Outcome Of EGM

Kilitch Drugs India Ltd has informed that the members at the Extra Ordinary General Meeting (EGM) of the Company held on May 28, 2007, inter alia, have accorded to the following:1. Increase in the Authorized Share Capital of the Company from Rs 10,00,00,000/- divided into 1,00,00,000 Equity Shares of Rs 10/- each to Rs 15,00,00,000/- divided into 1,50,00,000 Equity Shares of Rs 10/- each and consequential amendments in the Memorandum and Articles of Association of the Company.2. Authority to the Board to offer, issue and allot 6145000 Equity shares to the following allottees:i. NBZ Pharma Ltd (Promoter Group) - 6000000 No of Shares ii. Ms. Neha Rathi (Non Promoter) - 100000 No of Sharesiii. Ms. Pravina Mehta (Non Promoter) - 25000 No of Sharesiv. Mr. Sanjeev Nandu (Non Promoter) - 10000 No of Sharesv. Mr. Mahendra A Chheda (HUF) (Non Promoter) - 10000 No of Sharesof face value of Rs 10/- each at a subscription price of Rs 47.50/- per Equity share inclusive of premium of Rs 37.50/- per Equity Share, or at price as may be mutually agreed but not less than price calculated as per DIP Guidelines 13.1.1.1 being higher of the following:(a) The average of weekly high and low of the closing prices of the related shares quoted on the Stock exchange during the six months preceding the relevant date or (b) The average of weekly high and low of the closing prices of the related shares quoted on the stock exchange during the two weeks preceding the relevant data, per equity shares on a Preferential allotment basis for cash on the terms and conditions.